Comparison of the performances of two RNA-based geno-sensing principles for the detection of LncPCA3 biomarker
The most common prostate cancer (PCa) diagnostics which is based on detection of
prostate-specific antigen (PSA) in blood has specificity limitations often resulting in both …
prostate-specific antigen (PSA) in blood has specificity limitations often resulting in both …
Spectroscopic Ellipsometry Detection of Prostate Cancer Bio-Marker PCA3 Using Specific Non-Labeled Aptamer: Comparison with Electrochemical Detection
The most common prostate cancer (PCa) diagnostics, which are based on detection of
prostate-specific antigens (PSA) in blood, have specificity limitations often resulting in both …
prostate-specific antigens (PSA) in blood, have specificity limitations often resulting in both …
Optimization of apta-sensing platform for detection of prostate cancer marker PCA3
This work is a continuation of our research into the development of simple, reliable, and cost-
effective methods for the early diagnosis of prostate cancer (PCa). The proposed method is …
effective methods for the early diagnosis of prostate cancer (PCa). The proposed method is …
Detection of prostate cancer biomarker PCA3 with electrochemical apta-sensor
This is a continuation of our research into the development of novel biosensing technologies
for early diagnostics of prostate cancer (PCa). The existing PCa diagnostics based on PSA …
for early diagnostics of prostate cancer (PCa). The existing PCa diagnostics based on PSA …
Detection of prostate cancer biomarker PCA3 by using aptasensors
Background: Prostate cancer cells have very high PCA3 messenger RNA levels, which turns
them into one of the new biomarkers for prostate cancer prognosis and diagnosis. Objective …
them into one of the new biomarkers for prostate cancer prognosis and diagnosis. Objective …
[HTML][HTML] Ultrasensitive prostate cancer marker PCA3 detection with impedimetric biosensor based on specific label-free aptamers
Prostate cancer (PCa) appears among the most frequently diagnosed types of malignancies
in males. Because of the high demand and increasing detection rate of early PCa, alongside …
in males. Because of the high demand and increasing detection rate of early PCa, alongside …
Electrochemical detection of prostate cancer biomarker PCA3 using specific RNA-based aptamer labelled with ferrocene
This paper reports on a feasibility study of electrochemical in-vitro detection of prostate
cancer biomarker PCA3 (prostate cancer antigen 3) in direct assay with specific RNA …
cancer biomarker PCA3 (prostate cancer antigen 3) in direct assay with specific RNA …
Electrochemical Aptamer-Based Biosensor Developed to Monitor PCA3 and PSA Released by Prostate Cancer Cells
DA Pedrosa - Electrochemical Society Meeting Abstracts 244, 2023 - iopscience.iop.org
1. Introduction Detection of prostate cancer (PCa) in the early stage of the disease is
fundamental for the prevention of metastases and for the initiation of treatment, which may …
fundamental for the prevention of metastases and for the initiation of treatment, which may …
Enhanced performance electrochemical biosensor for detection of prostate cancer biomarker PCA3 using specific aptamer
In the quest for the development of accurate, reliable, and cost-effective biosensing
technology for early diagnostics of prostate cancer, we describe here an electrochemical …
technology for early diagnostics of prostate cancer, we describe here an electrochemical …
[HTML][HTML] Dual electrochemical genosensor for early diagnosis of prostate cancer through lncRNAs detection
R Sanchez-Salcedo, R Miranda-Castro… - Biosensors and …, 2021 - Elsevier
The prostate specific antigen (PSA) test is the gold standard for the screening of prostate
cancer (PCa), despite its limited clinical specificity. Long noncoding RNAs are released from …
cancer (PCa), despite its limited clinical specificity. Long noncoding RNAs are released from …